M. Sinet et al., EFFECTS OF CHLOROQUINE ON THE REPLICATION OF A MURINE RETROVIRUS, Bulletin de la Societe de pathologie exotique et de ses filiales, 89(3), 1996, pp. 175-178
The wide use of chloroquine (Cq) for prophylaxis and chemotherapy of m
alaria in Africa, and the increased spread of AIDS in areas of this co
ntinent where malaria is endemic, raised the question of a possible in
teraction between chloroquine intake and HIV infection. Indeed, hydrox
ychloroquine and chloroquine itself have been shown to inhibit HN-I re
plication in vitro, hydroxychloroquine being proposed as a potential u
seful adjunctive therapy in the treatment of HIV-1 infection, On the o
ther hand chloroquine has been reported to enhance the replication of
Semliki Sorest and encephalomyocarditis viruses in a mouse model. In a
n attempt to elucidate Cq effect on retroviral replication we have stu
died the effect of various concentrations of chloroquine in vitro (0.1
nmol/l to 25 mu mol/l) on Friend retrovirus (FV)-infected fibroblasts
of mice and in vivo (2 to 30 mg/kg) on FV-infected mice. No reduction
in the number of virus foci was Sound in chloroquine-treated fibrobla
sts cultures. In chloroquine treated-infected mice, no differences wer
e observed in the spleen weights, except an increase at 10 mg/kg. A de
crease in splenocyte virus titer was only observed at 10 and 30 mg/kg.
No differences in the median survival time was observed Lip to 30 mg/
kg. The authors concluded that chloroquine seemed to have variable eff
ects on viral replication in vivo depending on the dosage, but has no
influence on the course of FV-induced disease.